- “Sorrisi in Rosa”: Guardian angels return for breast prevention
- Advanced hepatocarcinoma: positive results from the Cabozantinib study, in which Humanitas also took part
- Advances in Research in Oncology and Hematology: live Facebook stream with Prof. Santoro, Prof. Simonelli and Dr. Rossi
- AIRC Research Days, in addition to Humanitas’ awareness-raising initiatives
- AYA, a clinical and social pathway for young adults facing cancer
- Bladder cancer: what are the risk factors?
- Breast and ovarian cancer: family history and genetic predisposition
- Breast cancer and endocrine therapy: the right balance of benefits and side effects
- Breast cancer: endocrine therapies and the risk of anxiety and depression
- Breast cancer: the new era of intelligent drugs
- Breast cancer: the patient at the heart of clinical studies
- Cancer and liver diseases: what is the correlation?
- Cancer immunotherapy: Prof. Mantovani participates in All-Russia Science in Moscow
- Cancer in adolescents and young adults: Humanitas launches the AYA project
- Cancer, that’s why it’s not just a matter of bad luck
- Cancer: the role of prevention and early diagnosis
- Cervical Oncology – Facial: Professor Giuseppe Spriano elected to the Executive Committee of IFHNOS and President of the World Congress 2022
- EASL 2018: The Role of the Medical Oncologist in the Multidisciplinary Management of Hepatic carcinoma, Dr. Rimassa’s Report
- Fertility in cancer patients: a conference held at Humanitas on 4 December
- Head and neck cancer: a day of prevention with free visits at Humanitas
